
Glucocorticoid resistance in critical illness limits treatment success, driven by GRα dysfunction, oxidative stress, epigenetic changes, and pharmacologic barriers. This framework highlights dose optimization, continuous infusion, biomarker-guided therapy, and adjuncts like antioxidants, melatonin, and probiotics to restore GRα signaling and improve outcomes across systems.
Like
Save
Share